Learn How to Pronounce brexpiprazole
(Listen to the audio above for the stress and intonation)
The Expert's Take

Meaning and Context
Brexpiprazole is an atypical antipsychotic medication, approved by the U.S. Food and Drug Administration (FDA) in 2015, that functions as a partial agonist at serotonin 5-HT1A and dopamine D2 receptors while antagonizing serotonin 5-HT2A receptors. This unique pharmacological profile underpins its primary clinical applications: the treatment of schizophrenia in adults and its use as an adjunctive therapy for major depressive disorder (MDD) when an antidepressant alone provides inadequate relief. Marketed under the brand name Rexulti, brexpiprazole represents a significant advancement in psychopharmacology, offering a treatment option often noted for a potentially favorable tolerability profile regarding weight gain and metabolic side effects compared to some older antipsychotics. Patients and healthcare providers frequently search for information on Rexulti dosage, brexpiprazole side effects like akathisia or weight changes, and its efficacy for depression and schizophrenia treatment, making it a key term in the realms of mental health medication and atypical antipsychotic drugs.
Common Mistakes and Alternative Spellings
The standard and correct spelling is "brexpiprazole." Common misspellings and typographical errors often arise from phonetic misinterpretation or keyboard slips. Frequent variations include "brexipiprazole" (transposing the 'i' and 'p'), "brexpiprizole" (substituting a 'z' for the second 'a'), and "brexpiperazole" (replacing 'pra' with 'pera'). Some may also mistakenly write "Brexiprazole" or "Brespiprazole," dropping a letter or confusing the 'x' with an 's'. It is also important to distinguish it from its predecessor, "aripiprazole" (Abilify), as the names are structurally similar and can be confused in clinical notes or by patients. The brand name "Rexulti" is occasionally misspelled as "Rexaulti," "Rexulti," or "Rexulty."
Example Sentences
After several weeks on a stable dose of brexpiprazole, the patient reported a noticeable reduction in the auditory hallucinations that had previously been debilitating.
The psychiatrist decided to add a low dose of brexpiprazole to the existing SSRI regimen to address the persistent anhedonia and low mood of the treatment-resistant major depressive disorder.
Common initial side effects of brexpiprazole can include restlessness or akathisia, which often necessitates a slow titration schedule.
When reviewing the pharmacoeconomic data, the hospital formulary committee considered the cost-effectiveness of brexpiprazole relative to other adjunctive therapies for depression.
The clinical trial data robustly supported the FDA approval of brexpiprazole for both schizophrenia and adjunctive treatment of MDD.
Sources and References
For the antipsychotic "brexpiprazole," I first checked the audio pronunciation in the Drugs.com monograph. I compared this with the recordings on Forvo. The phonetic breakdown on Wiktionary was useful for understanding its structure. I also used YouGlish to find it in medical conferences and patient education videos.
- https://en.wiktionary.org/wiki/brexpiprazole
- https://en.wikipedia.org/wiki/Brexpiprazole
- https://www.drugs.com/brexpiprazole.html
- https://www.drugs.com/monograph/brexpiprazole.html
- https://youglish.com/pronounce/brexpiprazole/english
Related Pronunciations
- How to pronounce Crexont
- How to pronounce Doryx
- How to pronounce palivizumab
- How to pronounce rivaroxaban
- How to pronounce avatrombopag